This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
FoxWayne Enterprises Acquisition Corp.(NasdaqCM:FOXW) dropped from NASDAQ Composite Index CI
Clover Inc. cancelled the acquisition of FoxWayne Enterprises Acquisition Corp. from a group of shareholders in a reverse merger transaction. CI
FoxWayne Enterprises Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Clover Inc. entered into a definitive business combination agreement to acquire FoxWayne Enterprises Acquisition Corp. from a group of shareholders for approximately $160 million in a reverse merger transaction. CI
FoxWayne Enterprises Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
FoxWayne Enterprises Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
FoxWayne Enterprises Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
FoxWayne Enterprises Acquisition Corp. Auditor Raises 'Going Concern' Doubt CI
Aerami Therapeutics Holdings, Inc. cancelled the acquisition of FoxWayne Enterprises Acquisition Corp. from FoxWayne Enterprises Acquisition Sponsor LLC and others in a reverse merger transaction. CI
Aerami Therapeutics to Go Public Via Merger with Blank-Check Firm FoxWayne Enterprises MT
FoxWayne Enterprises Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Foxwayne Enterprises Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Aerami Therapeutics Holdings, Inc. executed a non-binding letter of intent to acquire FoxWayne Enterprises Acquisition Corp. from FoxWayne Enterprises Acquisition Sponsor LLC and others for approximately $250 million in a reverse merger transaction. CI
Certain Class B Common Stock of FoxWayne Enterprises Acquisition Corp. are subject to a Lock-Up Agreement Ending on 19-JUL-2021. CI
Foxwayne Enterprises Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Foxwayne Enterprises Acquisition Corp. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020 CI
FoxWayne Enterprises Acquisition Corp. Auditor Raises 'Going Concern' Doubt CI
FoxWayne Enterprises Acquisition Corp.(NasdaqCM:FOXW) added to NASDAQ Composite Index CI
FoxWayne Enterprises Acquisition Corp. announced that it has received $2.8 million in funding from FoxWayne Enterprises Acquisition Sponsor LLC CI
FoxWayne Enterprises Acquisition Corp. has completed an IPO in the amount of $50 million. CI
FoxWayne Enterprises Acquisition Corp. has filed an IPO in the amount of $50 million. CI
FoxWayne Enterprises Acquisition Corp. announced that it expects to receive $2 million in funding from FoxWayne Enterprises Acquisition Sponsor LLC CI
FoxWayne Enterprises Acquisition Corp. announced that it has received $0.025 million in funding from FoxWayne Enterprises Acquisition Sponsor LLC CI
Chart FoxWayne Enterprises Acquisition Corp.
More charts
FoxWayne Enterprises Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company focuses for a target business in the biotechnology and/or telemedicine sector of the healthcare industry in North America. The Company has operations and has no revenues.
More about the company
  1. Stock Market
  2. Equities
  3. FOXW Stock
  4. News FoxWayne Enterprises Acquisition Corp.
  5. Aerami Therapeutics to Go Public Via Merger with Blank-Check Firm FoxWayne Enterprises